| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV | Director | Common Shares | 0 | $0 | $1.63 | 13 Nov 2025 | Direct |
| LAVA Therapeutics NV | Director | Common Shares (Right to Buy) | 33,390 | 13 Feb 2025 | Direct | ||
| Vaxart, Inc. | Director | Stock Option (right to buy) | 15,097 | 16 Jun 2021 | Direct | ||
| Serina Therapeutics, Inc. | Director | Stock Option (right to buy) | 10,000 | 07 Nov 2025 | Direct | ||
| Elicio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 7,900 | 19 May 2025 | Direct | ||
| LAVA Therapeutics NV | Director | Share Options (Right to Buy) | 0 | 13 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LVTX | LAVA Therapeutics NV | 13 Nov 2025 | 2 | $0 | 4 | Director | 17 Nov 2025, 16:30 |
| SER | Serina Therapeutics, Inc. | 07 Nov 2025 | 1 | $0 | 4 | Director | 10 Nov 2025, 19:30 |
| ELTX | Elicio Therapeutics, Inc. | 19 May 2025 | 1 | $0 | 4 | Director | 20 May 2025, 16:06 |
| LVTX | LAVA Therapeutics NV | 13 Feb 2025 | 1 | $0 | 4 | Director | 18 Feb 2025, 20:15 |
| SER | Serina Therapeutics, Inc. | 14 Jan 2025 | 1 | $0 | 4 | Director | 15 Jan 2025, 16:23 |
| SER | Serina Therapeutics, Inc. | 14 Jan 2025 | 0 | $0 | 3 | Director | 15 Jan 2025, 16:17 |
| LVTX | LAVA Therapeutics NV | 01 Jan 2025 | 0 | $0 | 3 | Director | 02 Jan 2025, 09:35 |
| ELTX | Elicio Therapeutics, Inc. | 21 Nov 2024 | 1 | $0 | 4 | Director | 25 Nov 2024, 16:05 |
| ELTX | Elicio Therapeutics, Inc. | 28 Dec 2023 | 1 | $0 | 4 | Director | 29 Dec 2023, 17:05 |
| ELTX | Angion Biomedica Corp. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 17:26 |
| VXRT | Vaxart, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 19:27 |